Insiders · Profile

Moore Matthew Richard

SVP and Chief Business Officer at Arcutis Biotherapeutics. Filing since 2 Mar 2023. CIK 0001840191

Company
Date
Role
Action
Shares
Amount
Of holding
2 May 2024
SVP and Chief Business Officer
Sold on a plan
4,681
$40.90K
3.1%
4 Mar 2024
SVP and Chief Business Officer
Sold on a plan
3,468
$38.57K
2.3%
2 Mar 2023
See Remarks
Sold, plan not stated
1,610
$25.48K
12.1%
3 decisions on file.